These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 37974228)
1. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma. Zhong Y; Yu F; Yang L; Wang Y; Liu L; Jia C; Cai H; Yang J; Sheng S; Lv Z; Weng L; Wu B; Zhang X J Transl Med; 2023 Nov; 21(1):817. PubMed ID: 37974228 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation. Zhong Z; Hu Z; Jiang Y; Sun R; Chen X; Chu H; Zeng M; Sun C Oncotarget; 2016 Sep; 7(37):59652-59663. PubMed ID: 27487122 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells. Zhang X; Liu L; Deng X; Li D; Cai H; Ma Y; Jia C; Wu B; Fan Y; Lv Z Oncogene; 2019 Jan; 38(5):699-715. PubMed ID: 30171257 [TBL] [Abstract][Full Text] [Related]
4. C5AR1-induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer. Liu B; Sun Y; Geng T; Wang H; Wu Z; Xu L; Zhang M; Niu X; Zhao C; Shang J; Shang F Mol Carcinog; 2024 Oct; 63(10):1938-1952. PubMed ID: 38934768 [TBL] [Abstract][Full Text] [Related]
5. miR-199a-5p suppresses epithelial- mesenchymal-transition in anaplastic thyroid carcinoma cells via targeting Snail signals. Hao F; Bi YN; Wang L; Wang Y; Ma J; Cui P; Li X; Sun S; Ning L; Huang Y; Jiao X; Chen D Cancer Biomark; 2020; 29(3):317-326. PubMed ID: 32716347 [TBL] [Abstract][Full Text] [Related]
6. GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma. Gao H; Wang W; Li Q Cancer Biol Ther; 2022 Dec; 23(1):369-377. PubMed ID: 35491899 [TBL] [Abstract][Full Text] [Related]
7. miR-451a inhibits cancer growth, epithelial-mesenchymal transition and induces apoptosis in papillary thyroid cancer by targeting PSMB8. Fan X; Zhao Y J Cell Mol Med; 2019 Dec; 23(12):8067-8075. PubMed ID: 31559672 [TBL] [Abstract][Full Text] [Related]
8. LncRNA H19 Influences Cellular Activities via the miR-454-3p/BHLHE40 Axis in Anaplastic Thyroid Carcinoma. Wu Y; Yang J; Zhang H; Cheng J; Lei P; Huang J Horm Metab Res; 2024 May; 56(5):392-399. PubMed ID: 38052232 [TBL] [Abstract][Full Text] [Related]
9. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway. Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349 [TBL] [Abstract][Full Text] [Related]
10. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD. Bu Q; You F; Pan G; Yuan Q; Cui T; Hao L; Zhang J Biomed Pharmacother; 2017 Apr; 88():443-448. PubMed ID: 28122310 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1. Gou L; Zou H; Li B Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506 [TBL] [Abstract][Full Text] [Related]
13. Ellagic acid inhibits cell proliferation, migration, and invasion of anaplastic thyroid cancer cells via the Wnt/β-catenin and PI3K/Akt pathways. Meng X; Cui Z; Shi H; Ma X; Li W; Liu X; Jiang Y Acta Biochim Pol; 2023 Feb; 70(1):109-115. PubMed ID: 36773307 [TBL] [Abstract][Full Text] [Related]
14. GAB1 is upregulated to promote anaplastic thyroid cancer cell migration through AKT-MDR1. Song P; Xu H; He Y; Sun J; Xu Z; Huang P; Ge M; Zhang X; Ke Y; Cheng H Biochem Biophys Res Commun; 2022 Jun; 607():36-43. PubMed ID: 35366541 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic gene RGC-32 is a direct target of miR-26b and facilitates tongue squamous cell carcinoma aggressiveness through EMT and PI3K/AKT signalling. Yang ZH; Li J; Chen WZ; Kong FS Cell Biochem Funct; 2020 Oct; 38(7):943-954. PubMed ID: 32325539 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1. Xu L; Sun HB; Xu ZN; Han XL; Yin YY; Zheng Y; Zhao Y; Wang ZX Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7978-7988. PubMed ID: 31599423 [TBL] [Abstract][Full Text] [Related]
17. M2‑like tumour‑associated macrophage‑secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway. Lv J; Liu C; Chen FK; Feng ZP; Jia L; Liu PJ; Yang ZX; Hou F; Deng ZY Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184083 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway. Xiao R; Wang H; Yang B Bioengineered; 2021 Dec; 12(2):10596-10607. PubMed ID: 34895048 [TBL] [Abstract][Full Text] [Related]
19. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-148a Inhibits Hepatocellular Carcinoma Cell Growth via Epithelial-to-Mesenchymal Transition and PI3K/AKT Signaling Pathways by Targeting Death Receptor-5. Zhang N; Zhou J; Zhou Y; Guan F Appl Biochem Biotechnol; 2022 Jun; 194(6):2731-2746. PubMed ID: 35267120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]